跳至主要内容
临床试验/PACTR202607567738879
PACTR202607567738879进行中(未招募)3 期

Microneedling with methotrexate versus intralesional steroid in the treatment of localized vitiligo

Al Azhar university0 个研究点目标入组 36 人开始时间: 2023年4月25日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Co-operative patient who is willing and able to comply with the treatment protocol and follow-up visits.
  • Participants must have stable vitiligo, meaning that the extent and severity of their vitiligo have not significantly changed in the past 6 months

排除标准

  • Patients with keloidal tendency.
  • Patients receiving topical or systemic treatment for vitiligo and phototherapy during the previous 6 months.
  • Patients with active lesions.
  • Participants with a history of hypersensitivity to methotrexate or any of its excipients.
  • Participants with a history of liver disease or liver function abnormalities.
  • Participants with a history of bleeding disorders or receiving anticoagulant therapy.
  • Participants who are pregnant or breastfeeding.
  • Participants with active skin infections or skin conditions that would contraindicate the use of microneedling or intralesional injections.

研究组 & 干预措施

;Intralesional steroids;Microneedling with methotrexate

干预措施: ;Intralesional steroids;Microneedling with methotrexate

研究者

相似试验